Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.
Source: https://www.cnbc.com/2024/04/24/biogen- ... 2024-.html
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
